RecruitingNCT07402577

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

Sponsor

Roswell Park Cancer Institute

Enrollment

40 participants

Start Date

Feb 22, 2026

Study Type

OBSERVATIONAL

Conditions

Sarcoma Childhood Sarcoma of Soft Tissue

Summary

This study generates information on the feasibility and acceptability of a 3-month ecological momentary assessment (EMA) protocol to assess chronic pain and opioid use in adolescent and young adult (AYA) sarcoma survivors.

Eligibility

Min Age: 12 YearsMax Age: 70 Years

Inclusion Criteria9

All genders between the ages of 12-24 (inclusive) at sarcoma diagnosis.
Any age \< 70 at the time of study enrollment.
No evidence of disease and/or enrolled in survivorship care.
Clinically meaningful pain related to disease or its treatments at baseline (defined as 3 or greater on a 0-10 Numerical Rating Scale).
Willing to attend the baseline appointment in person.
Access to internet-capable smartphone.
Access to internet on an occasional basis.
Willing and able to complete Ecological Momentary Assessments (EMAs) on internet-capable smartphone for a 3-month period after enrollment.
Ability to understand and provide informed consent/assent.

Exclusion Criteria5

\* Currently receiving active cancer-directed therapy.
Unable to read or fluently speak English.
Determined by clinical staff to have preexisting or cancer-associated cognitive impairment that could interfere with study participation.
Acutely suicidal (e.g. intent or plan) or, with unstable medical or psychiatric condition verified by licensed study staff.
Characteristics related to inability to complete the study protocol.